1. Home
  2. ATRC vs ICHR Comparison

ATRC vs ICHR Comparison

Compare ATRC & ICHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATRC
  • ICHR
  • Stock Information
  • Founded
  • ATRC 2000
  • ICHR 1999
  • Country
  • ATRC United States
  • ICHR United States
  • Employees
  • ATRC N/A
  • ICHR N/A
  • Industry
  • ATRC Medical/Dental Instruments
  • ICHR Semiconductors
  • Sector
  • ATRC Health Care
  • ICHR Technology
  • Exchange
  • ATRC Nasdaq
  • ICHR Nasdaq
  • Market Cap
  • ATRC 1.6B
  • ICHR 727.6M
  • IPO Year
  • ATRC 2005
  • ICHR 2016
  • Fundamental
  • Price
  • ATRC $31.39
  • ICHR $22.31
  • Analyst Decision
  • ATRC Strong Buy
  • ICHR Strong Buy
  • Analyst Count
  • ATRC 10
  • ICHR 6
  • Target Price
  • ATRC $49.60
  • ICHR $35.20
  • AVG Volume (30 Days)
  • ATRC 418.2K
  • ICHR 420.3K
  • Earning Date
  • ATRC 07-29-2025
  • ICHR 08-05-2025
  • Dividend Yield
  • ATRC N/A
  • ICHR N/A
  • EPS Growth
  • ATRC N/A
  • ICHR N/A
  • EPS
  • ATRC N/A
  • ICHR N/A
  • Revenue
  • ATRC $480,076,000.00
  • ICHR $892,122,000.00
  • Revenue This Year
  • ATRC $14.63
  • ICHR $14.18
  • Revenue Next Year
  • ATRC $12.62
  • ICHR $6.66
  • P/E Ratio
  • ATRC N/A
  • ICHR N/A
  • Revenue Growth
  • ATRC 15.79
  • ICHR 13.41
  • 52 Week Low
  • ATRC $20.20
  • ICHR $15.33
  • 52 Week High
  • ATRC $43.11
  • ICHR $42.70
  • Technical
  • Relative Strength Index (RSI)
  • ATRC 42.19
  • ICHR 72.23
  • Support Level
  • ATRC $31.88
  • ICHR $19.11
  • Resistance Level
  • ATRC $33.15
  • ICHR $17.86
  • Average True Range (ATR)
  • ATRC 1.07
  • ICHR 0.99
  • MACD
  • ATRC -0.09
  • ICHR 0.46
  • Stochastic Oscillator
  • ATRC 22.41
  • ICHR 96.58

About ATRC AtriCure Inc.

AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.

About ICHR Ichor Holdings

Ichor Holdings Ltd is engaged in the design, engineering, and manufacturing of critical fluid delivery subsystems and components for semiconductor capital equipment. The product offerings include gas and chemical delivery subsystems, collectively known as fluid delivery subsystems, which are key elements of the process tools used in the manufacturing of semiconductor devices. The company also manufactures machined components, weldments, and proprietary products for use in fluid delivery systems. Geographically, the company operates in the United States, Singapore, Europe, and Others, of which a majority of the revenue is generated from Singapore.

Share on Social Networks: